Blood Filtration And Purification Market To Reach $5.63 Billion By 2030

Blood Filtration And Purification Market Growth & Trends

The global blood filtration and purification market size is anticipated to reach USD 5.63 billion by 2030 and is projected to grow at a CAGR of 7.34% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key driving factors such as increasing prevalence of blood-borne diseases, growing geriatric population, rising awareness of blood purification therapies have fueled the market growth.

The blood filtration & purification industry in clinical diagnostics experienced a major surge during the COVID-19 pandemic, driven by the urgent need for effective treatment solutions for critically ill patients. Among the most vital tools during this period were advanced blood purification kits, which played a critical role in managing severe inflammatory responses, organ failure, and complications associated with the virus.

At the forefront of this innovation was OXIRIS, a multifunctional blood purification filter set—the only one available in the U.S. capable of performing Continuous Renal Replacement Therapy (CRRT) while simultaneously removing cytokines and inflammatory mediators from the blood. During the height of the pandemic, OXIRIS became a key therapeutic solution for managing critically ill COVID-19 patients who were experiencing cytokine storms, sepsis, and acute kidney injury. By efficiently removing inflammatory substances, the kit helped stabilize patients, reduce intensive care burden, and improve survival outcomes.

Thermo Scientific's GeneJET Whole Blood Genomic DNA Purification Mini Kit stands out for its rapid, spin-column-based silica membrane technology. This kit streamlines DNA extraction from whole blood, eliminating the need for hazardous phenol-chloroform extraction or time-consuming alcohol precipitation. With a standard protocol that takes under 20 minutes post-lysis, it delivers high molecular weight DNA (>30 kb), ready for downstream applications like PCR, Southern blotting, and enzymatic assays. The kit’s simplicity and reliability make it a preferred choice for laboratories looking to scale genomic diagnostics with speed and safety.

SpiNXT Blood DNA Extraction Kit is another innovative solution, designed for use with whole blood, plasma, serum, lymphocytes, and buffy coat. Combining silica-binding chemistry with a mini spin-column format, it ensures high-yield, high-purity DNA isolations across a range of blood-derived sample types. With no need for organic solvents or complicated equipment, the SpiNXT kit enables fast processing and compatibility with a wide array of clinical genetic assays.

Meanwhile, the sbeadex Blood DNA Purification Kit brings magnetic bead-based technology into focus. Designed for sample volumes up to 200 µL, the kit supports high-throughput automation workflows and is fully compatible with popular platforms like Thermo Fisher's KingFisher™ system. Its water-based wash buffers help eliminate carryover of organic solvents and PCR inhibitors, ensuring clean DNA suitable for sensitive applications such as qPCR, NGS, Sanger sequencing, and genetic disorder screening.

The pandemic highlighted the critical role of blood purification kits in managing high-risk patients. As healthcare systems adapted to the challenges of COVID-19, these kits became indispensable tools not only for diagnostic support but also for therapeutic intervention. Their impact has extended beyond the pandemic, with continued use in managing sepsis, kidney injury, and other inflammation-driven conditions.

The COVID-19 crisis accelerated the adoption of blood filtration and purification kits such as OXIRIS, CytoSorb, AMBER, and Hemoclear, setting a new benchmark for integrated clinical diagnostics and critical care. These innovations remain central to modern ICU practice, ensuring that the lessons learned during the pandemic translate into stronger, more responsive healthcare systems going forward.

 Request a free sample copy or view report summary: Blood Filtration And Purification Market Report

Blood Filtration And Purification Market Report Highlights

• The filtration kits & reagents segment led the market with the largest revenue share of 35.97% in 2024. This segment is expected to see rapid expansion due to its critical role in ensuring the safety and efficacy of blood transfusions, therapeutic treatments, and medical research. A key driving factor is the technological advancements in filtration materials, and a growing global demand for high-quality blood products further contributes to the dominance of filtration kits and reagents in the market.

• Based on application, the infectious disease diagnostics segment accounted for the largest market revenue share in 2024, due to the growing global prevalence of infectious diseases and the critical need for accurate, rapid diagnostics. The genetic/molecular diagnostics segment is expected to grow at the fastest CAGR over the forecast period, due to the increasing demand for precise, personalized healthcare solutions.

• Based on end use, the clinical diagnostics laboratories segment accounted for the largest market revenue share in 2024, due to their essential role in disease detection and monitoring. These laboratories rely on advanced filtration technologies to obtain high-quality, contaminant-free blood samples for accurate testing, especially in infectious disease diagnostics, genetic testing, and oncology. With the rise of personalized medicine and early disease detection, clinical diagnostic labs are adopting cutting-edge filtration technologies, driving both the size and growth of this market segment.

Blood Filtration And Purification Market Report Segmentation

Grand View Research has segmented the global blood filtration and purification market based on the product type, application type, end use type, and region:

Blood Filtration And Purification Product Outlook (Revenue, USD Million, 2018 - 2030)

• Filtration kits and Reagents

• Membranes, Filters and Consumables

• Sample preparation systems

• Specialty assays and columns

Blood Filtration And Purification Application Outlook (Revenue, USD Million, 2018 - 2030)

• Infectious Disease Diagnostics

• Toxicology and Immunodiagnostics

• Cancer Diagnostics

• Genetic/Molecular Diagnostics

• Others (Metabolic, Rare Disease Panels)

Blood Filtration And Purification End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Clinical Diagnostic Labs

• Hospitals

• Research and Academic Institutes

• Others

Blood Filtration And Purification Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Players in the Blood Filtration And Purification Market

• Thermo Fischer Scientific

• MilliporeSigma

• Roche Lifescience

• Sigma Aldrich

• Avantor

• Takara Bio

• MP Biomedicals.

• QIAGEN N.V

• HiMedia

• Biotage